Related Experiment Videos
In vitro granulocyte aggregation
1Department of Clinical Chemistry and Medical Rheumatology, Odense University Hospital, Denmark.
Scandinavian Journal of Clinical and Laboratory Investigation
|November 1, 1989
Summary
Rheumatoid arthritis patients may experience transient granulocyte aggregation in EDTA-blood, causing a temporary decrease in leukocyte counts. This phenomenon, observed multiple times, involves granulocyte clumping without platelet involvement.
Area of Science:
- Hematology
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
- Hematological parameters can be affected in patients with autoimmune conditions.
- The behavior of leukocytes, particularly granulocytes, in vitro is crucial for understanding immune responses.
Observation:
- Transient granulocyte aggregation was observed in ethylenediaminetetraacetic acid (EDTA)-treated blood samples from a patient with rheumatoid arthritis.
- This phenomenon recurred three times over a 10-month observation period.
- No involvement of thrombocytes (platelets) was detected in the observed aggregation.
Findings:
- A significant decrease of approximately 30% in leukocyte count was recorded by Coulter Counter within 6 hours of blood collection.
- The reduction in leukocyte count was temporary and did not lead to overt leukopenia.
- Microscopic examination of blood smears revealed a concurrent increase in the number of granulocyte aggregates.
Implications:
- This observation suggests a potential in vitro artifact or a specific immune-mediated phenomenon in RA patients affecting granulocytes.
- Understanding granulocyte aggregation in EDTA-blood may offer insights into RA pathogenesis or diagnostic markers.
- Further research is warranted to elucidate the mechanisms and clinical significance of this transient granulocyte aggregation in rheumatoid arthritis.